Winstrol

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf anabolic steroid
gptkbp:alsoKnownAs Stanozolol
gptkbp:approvalYear 1962
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode A14AA02
gptkbp:bannedIn gptkb:World_Anti-Doping_Agency
gptkbp:CASNumber 10418-03-8
gptkbp:category anabolic steroid
androgen
17α-alkylated steroid
gptkbp:chemicalFormula C21H32N2O
gptkbp:developedBy gptkb:Winthrop_Laboratories
gptkbp:discontinued United States (2010)
gptkbp:eliminationHalfLife 24 hours (intramuscular)
9 hours (oral)
gptkbp:firstSynthesized 1962
https://www.w3.org/2000/01/rdf-schema#label Winstrol
gptkbp:legalStatus prescription only (in most countries)
gptkbp:marketedAs gptkb:Winstrol
Stromba
Winstrol Depot
gptkbp:metabolism liver
gptkbp:molecularWeight 328.5 g/mol
gptkbp:notableEvent Ben Johnson stripped of 1988 Olympic gold medal for Winstrol use
gptkbp:notableFor performance enhancement
muscle growth
cutting cycles in bodybuilding
gptkbp:notableUser gptkb:Ben_Johnson
gptkbp:origin synthetic
gptkbp:pregnancyCategory X (contraindicated)
gptkbp:prohibits sports
gptkbp:proteinBinding high
gptkbp:relatedTo testosterone
gptkbp:routeOfAdministration oral
intramuscular injection
gptkbp:sideEffect hair loss
acne
liver toxicity
increased cholesterol
virilization in women
gptkbp:solubility low
gptkbp:usedBy athletes
bodybuilders
gptkbp:usedFor gptkb:anemia
muscle wasting diseases
treatment of hereditary angioedema
gptkbp:bfsParent gptkb:stanozolol
gptkbp:bfsLayer 8